DAEWOONG PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 069620 for the last quarter is 360.54 B KRW, and it's 7.37% higher compared to the previous quarter. The net income of Q2 24 is 1.14 B KRW.